Xingmei Zhang

Company: Hansa Biopharma

Job title: Franchise Program Lead

Seminars:

IgG Cleaving Enzymes as a Potential Solution to the NAb Challenge 11:45 am

An overview of IgG cleaving enzymes: their MOA and translatability for use in conjunction with gene therapies Discussing clinical data from non-gene therapy indications Considerations for treatment timing and dosing of gene therapy post-administration of enzymeRead more

day: Day 2 CLINICAL AM